New medical saline factory opened in Sulaimani

08-03-2024
Rudaw
A+ A-
ERBIL, Kurdistan Region - A new factory producing medical saline solutions opened on Thursday in Sulaimani, with Iraq’s minister of health presiding over its inauguration.

The factory is the first for Sulaimani-based PiONEER Co. to export its products, including Zhenaw, a saline solution administered to patients who need to replenish the body’s nutrients and minerals, beyond the local market. 

PiONEER Co. for Pharmaceutical Industries, founded in 2011 in Iraq, is specialized in the production of both generic and branded medicines, and boasts over 200 products on the market.

Iraqi Health Minister Salih al-Hasnawi, who attended the inauguration of the new factory, hailed the company for its achievements and said Baghdad remains open to help local businesses to reach their potential.

"It is the first pharmaceutical factory whose products are exported outside the country. This represents our pride, makes every Iraqi proud," said al-Hasnawi during a press conference attended by Iraqi and Kurdish officials, including his Kurdistan Regional Government (KRG) counterpart. 

PiONEER Co. currently exports its products to the Sultanate of Oman, the United Arab Emirates and soon to Jordan. 

Hasnawi added that the Iraqi ministry of health is increasingly more reliant on homegrown factories for locally-produced medicines. 

"Our contract with PiONEER co. for Pharmaceutical Industries was worth about 23 billion IQD in 2022, it then increased to 86 billion IQD in 2023, and we are expecting this volume to increase in 2024," he said. 

KRG's Minister of Health Saman Barzinji said that PiONEER is currently producing 17 saline solutions. 

The company's official website states that it employs over 1,300 workers, 95 percent of whom are locals. 

PiONEER’s main competitor in the Kurdistan Region is Awamedica, which is based in Erbil and has over 200 products on the market.
 

Comments

Rudaw moderates all comments submitted on our website. We welcome comments which are relevant to the article and encourage further discussion about the issues that matter to you. We also welcome constructive criticism about Rudaw.

To be approved for publication, however, your comments must meet our community guidelines.

We will not tolerate the following: profanity, threats, personal attacks, vulgarity, abuse (such as sexism, racism, homophobia or xenophobia), or commercial or personal promotion.

Comments that do not meet our guidelines will be rejected. Comments are not edited – they are either approved or rejected.

Post a comment

Required
Required